Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Last revisionBoth sides next revision
serum_biomarkers_for_neurodegeneration [2019/12/03 23:11] – adminserum_biomarkers_for_neurodegeneration [2019/12/19 23:47] – [Data] admin
Line 1: Line 1:
 +====== Serum biomarkers for neurodegeneration ======
 +
 ===== Objectives ===== ===== Objectives =====
  
-Identify novel serum biomarkers for neurodegeneration that allow accurate diagnosis of Alzheimer's disease (AD) in Hispanic and non-Hispanic white populations.+Identify novel serum biomarkers for neurodegeneration that allow accurate diagnosis of Alzheimer's disease (AD) in Hispanic and non-Hispanic white populations (Specific {{:analysis_plan.docx|Aims}} ). 
 + 
 +===== Data ===== 
 + 
 +  - Six proteins were measured in blood samples of ~1200 Hispanic and ~500 non-Hispanic white participants. Covariates include gender, education, and age. 
 +  - The cognitive status of participants were assessed in several visits over years. The number of visits and time intervals between visits vary across participants. 
 + 
 + 
 +===== Collaborators ===== 
 + 
 +Dr. Sudha [[https://www.uthscsa.edu/academics/biomedical-sciences/faculty/profile/53266/Seshadri,-Sudha|Seshadri]], the Founding director of the Glenn [[https://biggsinstitute.org/|Biggs]] Institute for Alzheimer's & Neurodegenerative Diseases, and Dr. Mitzi [[https://biggsinstitute.org/team-member/mitzi-m-gonzales-ph-d/|Gonzales]] from the Department of Neurology at University of Texas Health Science Center in San Antonio. This study is supported by Texas Alzheimer's Research and Care Consortium (TARCC). 
 + 
 + 
 +===== Analysis ===== 
 + 
 +  - Linear models. 
 +  - Regularized regression, e.g., the LASSO. 
 +  - Hidden Markov Models (HMM). 
 + 
 + 
 +===== Related work ===== 
 + 
 +  - Eagan, Danielle E., et al. "Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults." Cardiovascular psychiatry and neurology 2012 ([[https://www.hindawi.com/journals/cpn/2012/120540/|2012]]).